Athira Pharma

Recent Finacing

Series B

Recent Raise

$85M

Athira Pharma is a Seattle-based clinical-stage biopharmaceutical company developing NDX-1017, a small-molecule regenerative therapy in Phase 2/3 trials to restore neuronal connections and cognitive function in Alzheimer's.

Founded 2011

Washington, United States

51-100

Publicly Traded

athira.com

Highlights

Focus Areas

Biotechnology

Pharmaceutical

Therapeutics

Recent Investors

H

Financials

$86.4M

Total Raised

2

Funding rounds

16

Investors

Team

Upgrade to view the team

See the team members at Athira Pharma.